Cuban & eMed: Disrupting Healthcare Marketing at SXSW
Cuban and eMed Challenge Direct-to-Consumer GLP-1 Drug Models at SXSW March 15, 2026 Austin, TX – A sharp contrast in philosophies regarding access to GLP-1 medications emerged at South by Southwest (SXSW) this week, as Mark Cuban, co-founder of Cost Plus Drugs, and Linda Yaccarino, CEO of eMed Population Health, publicly differentiated their approaches from … Read more